サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541208

末梢動脈疾患市場レポート：タイプ、エンドユーザー、地域別、2024年～2032年

Peripheral Artery Disease Market Report by Type, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 146 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
末梢動脈疾患市場レポート：タイプ、エンドユーザー、地域別、2024年～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢動脈疾患市場規模は2023年に46億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて5.2%の成長率（CAGR）を示し、2032年には74億米ドルに達すると予測しています。

末梢動脈疾患（PAD）は、動脈の収縮によって手足の血流が制限される心血管系の疾患です。その結果、脱毛、脚のしびれ、足や足指のただれ、臀部や大腿部の痛みを伴うけいれん、脚の冷えや脈の弱さ、男性の勃起不全が生じる。心臓から腕や脚に酸素と栄養豊富な血液を運ぶ脚の動脈に、アテローム性動脈硬化症としても知られるプラークが発生することで発症します。足関節上腕血圧比、超音波検査、血管造影、血液検査、ドップラーおよび超音波（デュプレックス）画像、コンピュータ断層撮影（CT）、磁気共鳴血管造影（MRA）などを用いて診断されます。

末梢動脈疾患市場動向：

現在，世界中で老年人口が増加しています。これは、個人のライフスタイルの変化、不健康な食事パターンの増加、アルコール依存症、運動不足による肥満などとともに、市場を牽引する主な要因の1つとなっています。さらに、術後の痛みが少ない、手術後や術後の合併症が少ない、入院期間が短い、回復が早い、免疫系への負担が少ないなどの理由から、低侵襲手術（MIS）の採用が増加しています。これはヘルスケア産業の拡大と相まって、市場の成長を後押ししています。さらに、いくつかの国の政府は、PADデバイスの利点についての認識を広めるための取り組みを行っており、これは市場にプラスの影響を与えています。これに加えて、世界中の個人の間で心疾患の有病率が上昇しており、業界の投資家に有利な成長機会を提供しています。さらに、主要な市場プレーヤーは、PAD治療能力を強化するために合併買収（M&A）に注力しています。これらの企業はまた、全体的な収益性を強化すると予測される様々な開発戦略にも注力しています。

本レポートで扱う主な質問

  • 世界の末梢動脈疾患市場の市場規模は？
  • 2024-2032年における末梢動脈疾患市場の世界市場成長率は？
  • 世界の末梢動脈疾患市場を牽引する主要因は何か？
  • 世界の末梢動脈疾患市場に対するCOVID-19の影響は？
  • 世界の末梢動脈疾患市場のタイプ別内訳は？
  • 末梢動脈疾患市場の世界における主要地域は？
  • 世界の末梢動脈疾患市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の末梢動脈疾患市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 末梢血管形成術用バルーン
    • 市場動向
    • 市場予測
  • 末梢ステント
    • 市場動向
    • 市場予測
  • 末梢カテーテル
    • 市場動向
    • 市場予測
  • 下大静脈（IVC）フィルター
    • 市場動向
    • 市場予測
  • プラーク修正装置
    • 市場動向
    • 市場予測
  • 血行動態血流調節装置
    • 市場動向
    • 市場予測
  • 周辺機器アクセサリ
    • 市場動向
    • 市場予測

第7章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 専門クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • AngioDynamics
    • B. Braun Melsungen AG
    • Becton Dickinson and Company
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Cook Medical LLC
    • Koninklijke Philips N.V.
    • Medtronic plc
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Peripheral Artery Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Peripheral Artery Disease Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Peripheral Artery Disease Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Peripheral Artery Disease Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Peripheral Artery Disease Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Peripheral Artery Disease Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Peripheral Artery Disease (Peripheral Angioplasty Balloons) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Peripheral Artery Disease (Peripheral Angioplasty Balloons) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Peripheral Artery Disease (Peripheral Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Peripheral Artery Disease (Peripheral Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Peripheral Artery Disease (Peripheral Catheters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Peripheral Artery Disease (Peripheral Catheters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Peripheral Artery Disease (Inferior Vena Cava (IVC) Filters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Peripheral Artery Disease (Inferior Vena Cava (IVC) Filters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Peripheral Artery Disease (Plaque Modification Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Peripheral Artery Disease (Plaque Modification Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Peripheral Artery Disease (Hemodynamic Flow Alteration Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Peripheral Artery Disease (Hemodynamic Flow Alteration Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Peripheral Artery Disease (Peripheral Accessories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Peripheral Artery Disease (Peripheral Accessories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Peripheral Artery Disease (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Peripheral Artery Disease (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Peripheral Artery Disease (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Peripheral Artery Disease (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Peripheral Artery Disease (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Peripheral Artery Disease (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: North America: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: North America: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: United States: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: United States: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Canada: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Canada: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Asia-Pacific: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Asia-Pacific: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: China: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: China: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Japan: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Japan: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: India: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: India: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: South Korea: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: South Korea: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Australia: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Australia: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Indonesia: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Indonesia: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Others: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Europe: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Europe: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Germany: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Germany: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: France: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: France: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United Kingdom: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United Kingdom: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Italy: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Italy: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Spain: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Spain: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Russia: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Russia: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Latin America: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Latin America: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Brazil: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Brazil: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Mexico: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Mexico: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Middle East and Africa: Peripheral Artery Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Middle East and Africa: Peripheral Artery Disease Market: Breakup by Country (in %), 2023
  • Figure 75: Middle East and Africa: Peripheral Artery Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Global: Peripheral Artery Disease Industry: SWOT Analysis
  • Figure 77: Global: Peripheral Artery Disease Industry: Value Chain Analysis
  • Figure 78: Global: Peripheral Artery Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peripheral Artery Disease Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Peripheral Artery Disease Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Peripheral Artery Disease Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Peripheral Artery Disease Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Peripheral Artery Disease Market: Competitive Structure
  • Table 6: Global: Peripheral Artery Disease Market: Key Players
目次
Product Code: SR112024A5822

The global peripheral artery disease market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA).

Peripheral Artery Disease Market Trends:

At present, there is a rise in the geriatric population across the globe. This, along with changing lifestyles of individuals, increasing adoption of unhealthy dietary patterns, alcoholism, and obesity on account of lack of physical activities, represents one of the key factors driving the market. Moreover, there is an increase in the adoption of minimally invasive surgeries (MIS) due to less postoperative pain, fewer operative and major postoperative complications, shortened hospital stay, faster recovery times, and less stress on the immune system. This, coupled with the expanding healthcare industry, is propelling the growth of the market. In addition, governments of several countries are undertaking initiatives to spread awareness about the benefits of PAD devices, which is positively influencing the market. Besides this, the rising prevalence of cardiac diseases among individuals around the world is offering lucrative growth opportunities to industry investors. Furthermore, key market players are focusing on mergers and acquisitions (M&A) to strengthen PAD treatment capabilities. These players are also focusing on various developmental strategies, which are projected to bolster their overall profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral artery disease market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type and end user.

Breakup by Type:

Peripheral Angioplasty Balloons

Peripheral Stents

Peripheral Catheters

Inferior Vena Cava (IVC) Filters

Plaque Modification Devices

Hemodynamic Flow Alteration Devices

Peripheral Accessories

Breakup by End User:

Hospitals

Specialty Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc and Terumo Corporation.

Key Questions Answered in This Report

  • 1. How big is the global peripheral artery disease market?
  • 2. What is the expected growth rate of the global peripheral artery disease market during 2024-2032?
  • 3. What are the key factors driving the global peripheral artery disease market?
  • 4. What has been the impact of COVID-19 on the global peripheral artery disease market?
  • 5. What is the breakup of the global peripheral artery disease market based on the type?
  • 6. What are the key regions in the global peripheral artery disease market?
  • 7. Who are the key players/companies in the global peripheral artery disease market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peripheral Artery Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Peripheral Angioplasty Balloons
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Peripheral Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Peripheral Catheters
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Inferior Vena Cava (IVC) Filters
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Plaque Modification Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hemodynamic Flow Alteration Devices
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Peripheral Accessories
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Specialty Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AngioDynamics
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 B. Braun Melsungen AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Becton Dickinson and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Biotronik SE & Co. KG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Boston Scientific Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Cardinal Health Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Cook Medical LLC
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 SWOT Analysis
    • 13.3.9 Koninklijke Philips N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Medtronic plc
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Terumo Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis